查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555516

外用抗生素市场、副产品、药物、应用、配销通路和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Topical Antibiotics Market, By Product, By Drug, By Application, By Distribution Channel, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年，外用抗生素市场规模为 53.152 亿美元，2024 年至 2032 年复合年增长率为 5.00%。

外用抗生素市场-市场动态

皮肤感染盛行率的增加支持外用抗生素市场的成长

据世界卫生组织称，全球约有 9 亿人患有蜂窝性组织炎、细菌性皮肤炎、痤疮和脓疱疮等皮肤病。不发达国家的主要原因之一是传染病。由细菌引起的皮肤感染在患有某些合併症的人中也更常见。这些疾病包括糖尿病、血管功能不全和免疫系统受损，特别是在接受化疗且出现嗜中性白血球减少症的个体中。在全球范围内，由于生活方式的改变、卫生习惯不良（特别是在发展中国家）以及速食摄入量的增加等多种因素，细菌性皮肤感染的盛行率一直在增加。因此，皮肤感染盛行率的上升推动了对局部抗生素治疗细菌性皮肤病的需求。

外用抗生素市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 5.00% 左右的复合年增长率成长

根据产品细分，预计软膏类别将在 2023 年占据最大市场份额

从药品细分来看，2023年四环素类为主导细分市场

从应用细分来看，皮肤感染类是2023年的主导细分领域

按地区划分，北美是 2023 年的主要收入来源

外用抗生素市场-細項分析：

全球外用抗生素市场根据产品、药物、应用、配销通路和地区进行细分。

市面上依药物分为以下几类：氨基糖苷类、四环素、红霉素、克林霉素等。四环素类别在市场上占据主导地位。四环素透过防止细菌生长和繁殖而发挥作用。许多皮肤感染，包括红斑性痤疮、痤疮和细菌性表浅皮肤感染，已被证明对四环素治疗有良好的反应。它有效应对这些情况的能力提高了其市场需求。四环素对多种细菌有效，包括革兰氏阳性菌和革兰氏阴性菌。其适应性使其成为治疗多种细菌性疾病的首选，从而推动了其市场扩张。

根据配销通路，市场分为三类：医院药房、零售药房和其他。零售药局类别在市场中占据主导地位，并可能在预测期内保持其主导地位。消费者可以轻鬆前往零售药局和药局，那里提供各种处方药和非处方药，包括外用抗生素。无论人们是想要治疗轻微感染，还是医疗保健专业人员开出局部抗生素处方，这些商店都是购买抗生素的便利场所。零售药局也经常提供药物咨询等额外服务，从而提高客户满意度和忠诚度。因此，零售药局和药局通路的广泛覆盖范围和易用性增强了其市场主导地位。

外用抗生素市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

在预测期内，北美预计将占据全球外用抗生素市场的最大份额。皮肤感染很常见，包括脓疱疮和细菌感染。皮肤病具有传染性，原因有很多，包括清洁不足、拥挤环境中的亲密接触以及特定的危险因子。由于皮肤感染盛行率的增加，对有效抗菌霜的需求不断增长。在美国，对于 1 岁至 19 岁的儿童来说，烧伤和火灾是伤害相关死亡的第七大常见原因。在北美，药品市场的成长在一定程度上要归功于强大的医疗基础设施。

此外，亚太地区的外用抗生素市场预计在预测期内将以全球最快的速度扩张。预计该地区对皮肤科抗生素的需求将受到中国和印度等人口稠密国家不断增长的人口密度和不卫生条件的推动。由于有利的监管环境、大量的研究支出以及与全球製药公司的合作，亚太地区的製药业正在快速成长。

外用抗生素市场-竞争格局：

竞争激烈的外用抗生素市场有多家参与者。辉瑞公司（Pfizer Inc.）、诺华公司（Novartis AG）、拜耳公司（Bayer AG）、礼来公司（Lilly）、默克公司（Merck & Co., Inc.）和太阳製药工业有限公司（Sun Pharmaceutical Industries Ltd.）等主要参与者正在透过满足各种治疗需求的各种产品组合积极争取市场份额。竞赛重点在于产品功效、安全性、成本和分销等多个重要方面，凸显创新对于阻止抗生素抗药性和维持市场竞争力的重要性。

最新进展：

2024 年1 月：美国市场即将迎来CABTREO™（克林霉素、阿达帕林、过氧化苯甲酰）外用凝胶1.2%/0.15%/3.1%，这是Bausch Health Companies Inc. 及其皮肤科部门Ortho Dermatologics 的新产品。该凝胶旨在帮助患有寻常性痤疮的成人和 12 岁或以上的青少年。

2023 年12 月：FDA 已批准Filsuvez，一种含有桦木三萜的外用凝胶，用于治疗6 个月或以上的交界性大疱性表皮鬆解症(JEB) 和营养不良性大疱性表皮松解症(DEB) 患者的部分厚度伤口。

目录

第一章：外用抗生素市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品分类的外用抗生素市场片段
    • 按药物分類的外用抗生素市场片段
    • 依应用分类的外用抗生素市场片段
    • 按配销通路分類的外用抗生素市场片段
    • 按国家/地区分類的外用抗生素市场摘要
    • 按地区分類的外用抗生素市场片段
  • 竞争洞察

第 3 章：外用抗生素主要市场趋势

  • 外用抗生素市场驱动因素
    • 市场驱动因素的影响分析
  • 外用抗生素市场限制
    • 市场限制影响分析
  • 外用抗生素市场机会
  • 外用抗生素市场未来趋势

第 4 章：外用抗生素产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：外用抗生素市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：外用抗生素市场格局

  • 2023 年外用抗生素市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：外用抗生素市场 - 副产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 乳霜
    • 药膏
    • 凝胶
    • 粉末
    • 其他的

第 8 章：外用抗生素市场 - 按药物分类

  • 概述
    • 按药物分類的细分市场份额分析
    • 氨基糖苷类
    • 四环素
    • 红霉素
    • 克林霉素
    • 其他的

第 9 章：外用抗生素市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 眼部感染
    • 皮肤感染
    • 狐狸臭
    • 其他的

第 10 章： 外用抗生素市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院药房
    • 零售药局
    • 其他的

第 11 章：外用抗生素市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美局部用抗生素主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按药物）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲局部用抗生素主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按产品）
    • 欧洲市场规模与预测（按药品）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区外用抗生素主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区药物市场规模与预测
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲局部用抗生素主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按药品）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲局部用抗生素主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按药品）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 外用抗生素产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Novartis AG
    • Bayer AG
    • Lilly
    • Merck & Co., Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Lupin
    • GlaxoSmithKline Plc
    • Almirall, SA
    • Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
    • Medimetriks Pharmaceuticals, Inc.
    • Taro Pharmaceutical Industries Ltd.
    • Chiesi Global Rare Diseases
    • Mayne Pharma Group Limited
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3578

REPORT HIGHLIGHT

Topical Antibiotics Market size was valued at USD 5,315.2 Million in 2023, expanding at a CAGR of 5.00% from 2024 to 2032.

Topical antibiotics are medications that are administered topically to the skin or mucous membranes in order to treat bacterial infections. They come in a variety of forms, including lotions, creams, ointments, gels, and solutions. Common causes of bacterial infections include Staphylococcus aureus, Streptococcus viridians, and Streptococcus pyogenes. High concentrations of antibiotics at the infection site are necessary for effective treatment; retapamulin and mugirocin are common options. When the skin is unbroken, very little systemic absorption takes place. Even though many infections may be treated outside of hospitals, there are serious hazards involved in leaving situations untreated.

Topical Antibiotics Market- Market Dynamics

Increase in Skin Infection Prevalence Supporting Market Growth for Topical Antibiotics

According to the World Health Organization, about 900 million individuals worldwide suffer from skin conditions like cellulitis, bacterial dermatitis, acne, and impetigo impact. One of the main causes of death in underdeveloped nations is infectious diseases. Skin infections caused by germs are also more common in people with certain comorbid diseases. These ailments include diabetes, vascular insufficiency, and impaired immune systems, particularly in individuals receiving chemotherapy who experience neutropenia. Globally, the prevalence of bacterial skin infections has been increasing due to various factors such as alterations in lifestyle, inadequate hygiene habits, particularly in developing nations, and increased intake of fast food. Thus, the need for topical antibiotics for bacterial skin illnesses is being driven by the rising prevalence of skin infections.

Topical Antibiotics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.00% over the forecast period (2024-2032)

Based on product segmentation, the ointments category was predicted to show maximum market share in the year 2023

Based on drug segmentation, the tetracycline category was the leading segment in 2023

Based on application segmentation, the skin infection category was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Topical Antibiotics Market- Segmentation Analysis:

The Global Topical Antibiotics Market is segmented on the basis of Product, Drug, Application, Distribution Channel and Region.

The market is divided into the following categories based on drug: Aminoglycosides, Tetracycline, Erythromycin, Clindamycin, and Others. The tetracycline category dominates the market. Tetracycline works by preventing bacterial growth and multiplication. Numerous skin infections, including rosacea, acne, and bacterial superficial skin infections, have been shown to respond well to tetracycline treatment. Its ability to effectively combat these situations raises its market demand. Tetracycline is effective on a wide range of bacteria, including Gram-positive and Gram-negative species. Its adaptability makes it a top option for treating a variety of bacterial diseases, which fuels its market expansion.

The market is divided into three categories based on distribution channel: Hospital Pharmacies, Retail Pharmacies, and Others. The retail pharmacies category dominates the market and is likely to maintain its dominance during the forecast period. Consumers can easily access retail pharmacies and drug stores, which provide a variety of prescription and over-the-counter drugs, including topical antibiotics. Whether people are looking to treat minor infections or are prescribed topical antibiotics by healthcare professionals, these stores are convenient places to buy them. Retail pharmacies also frequently offer extra services like medication counseling, which increases customer satisfaction and loyalty. Consequently, retail pharmacies and drugstore channels' extensive reach and ease of use add to their market domination.

Topical Antibiotics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Topical Antibiotics. Skin infections are common, including impetigo and bacterial infections. Skin disorders are contagious because of a number of circumstances, including inadequate cleanliness, close closeness in crowded settings, and particular risk factors. The need for effective antimicrobial creams is growing due to the increased prevalence of skin infections. In children between the ages of one and nineteen, burns and fires are the seventh most common cause of injury-related deaths in the US. In North America, the pharmaceutical market is growing thanks in part to a strong healthcare infrastructure.

In addition, the Topical Antibiotics market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The need for dermatological antibiotics in the region is expected to be driven by the growing population density and unhygienic conditions found in populated countries like China and India. The Asia Pacific region's pharmaceutical industry is growing quickly thanks to favorable regulatory environments, significant research expenditures, and cooperative efforts with global pharmaceutical companies.

Topical Antibiotics Market- Competitive Landscape:

There are several players in the fiercely competitive topical antibiotics market. Major players such as Pfizer Inc., Novartis AG, Bayer AG, Lilly, Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd., among others, are aggressively competing for market share with a variety of product portfolios catered to various therapeutic specializations. The competition focuses on a number of important aspects, such as product efficacy, safety, cost, and distribution, highlighting how crucial innovation is to halting antibiotic resistance and maintaining market competitiveness.

Recent Developments:

January 2024: The US market is set to welcome CABTREOTM (clindamycin, adapalene, benzoyl peroxide) Topical Gel, 1.2%/0.15%/3.1%, as a new product from Bausch Health Companies Inc. and Ortho Dermatologics, their dermatological division. This gel is designed to aid adults and teenagers with acne vulgaris who are 12 years of age or older.

December 2023: The FDA has approved Filsuvez, a topical gel containing birch triterpenes, for the treatment of partial thickness wounds in patients with Junctional Epidermolysis Bullosa (JEB) and Dystrophic Epidermolysis Bullosa (DEB) who are six months of age or older, according to a statement released by Chiesi Global Rare Diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TOPICAL ANTIBIOTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Lilly
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • GlaxoSmithKline Plc
  • Almirall, S.A.
  • Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
  • Medimetriks Pharmaceuticals, Inc.
  • Taro Pharmaceutical Industries Ltd.
  • Chiesi Global Rare Diseases
  • Mayne Pharma Group Limited
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Creams
  • Ointments
  • Gels
  • Powder
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032

  • Aminoglycosides
  • Tetracycline
  • Erythromycin
  • Clindamycin
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Eye Infection
  • Skin Infection
  • Bromhidrosis
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Topical Antibiotics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Topical Antibiotics Market Snippet by Product
    • 2.1.2. Topical Antibiotics Market Snippet by Drug
    • 2.1.3. Topical Antibiotics Market Snippet by Application
    • 2.1.4. Topical Antibiotics Market Snippet by Distribution Channel
    • 2.1.5. Topical Antibiotics Market Snippet by Country
    • 2.1.6. Topical Antibiotics Market Snippet by Region
  • 2.2. Competitive Insights

3. Topical Antibiotics Key Market Trends

  • 3.1. Topical Antibiotics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Topical Antibiotics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Topical Antibiotics Market Opportunities
  • 3.4. Topical Antibiotics Market Future Trends

4. Topical Antibiotics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Topical Antibiotics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Topical Antibiotics Market Landscape

  • 6.1. Topical Antibiotics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Topical Antibiotics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Creams
    • 7.1.3. Ointments
    • 7.1.4. Gels
    • 7.1.5. Powder
    • 7.1.6. Others

8. Topical Antibiotics Market - By Drug

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug, 2023 & 2032 (%)
    • 8.1.2. Aminoglycosides
    • 8.1.3. Tetracycline
    • 8.1.4. Erythromycin
    • 8.1.5. Clindamycin
    • 8.1.6. Others

9. Topical Antibiotics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Eye Infection
    • 9.1.3. Skin Infection
    • 9.1.4. Bromhidrosis
    • 9.1.5. Others

10. Topical Antibiotics Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 10.1.2. Hospital Pharmacies
    • 10.1.3. Retail Pharmacies
    • 10.1.4. Others

11. Topical Antibiotics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Topical Antibiotics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Topical Antibiotics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Topical Antibiotics Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Topical Antibiotics Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Topical Antibiotics Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Topical Antibiotics Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Novartis AG
    • 12.2.3. Bayer AG
    • 12.2.4. Lilly
    • 12.2.5. Merck & Co., Inc.
    • 12.2.6. Sun Pharmaceutical Industries Ltd.
    • 12.2.7. Aurobindo Pharma
    • 12.2.8. Lupin
    • 12.2.9. GlaxoSmithKline Plc
    • 12.2.10. Almirall, S.A.
    • 12.2.11. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
    • 12.2.12. Medimetriks Pharmaceuticals, Inc.
    • 12.2.13. Taro Pharmaceutical Industries Ltd.
    • 12.2.14. Chiesi Global Rare Diseases
    • 12.2.15. Mayne Pharma Group Limited
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us